nodes	percent_of_prediction	percent_of_DWPC	metapath
Dantrolene—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.123	0.248	CbGbCtD
Dantrolene—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0932	0.188	CbGbCtD
Dantrolene—CYP3A4—Betamethasone—ankylosing spondylitis	0.08	0.161	CbGbCtD
Dantrolene—CYP3A4—Prednisolone—ankylosing spondylitis	0.0789	0.159	CbGbCtD
Dantrolene—CYP3A4—Prednisone—ankylosing spondylitis	0.0745	0.15	CbGbCtD
Dantrolene—RYR3—Stimuli-sensing channels—ANO6—ankylosing spondylitis	0.047	0.298	CbGpPWpGaD
Dantrolene—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0465	0.0938	CbGbCtD
Dantrolene—RYR1—Stimuli-sensing channels—ANO6—ankylosing spondylitis	0.0347	0.22	CbGpPWpGaD
Dantrolene—RYR3—Ion channel transport—ANO6—ankylosing spondylitis	0.0307	0.194	CbGpPWpGaD
Dantrolene—RYR1—Ion channel transport—ANO6—ankylosing spondylitis	0.0226	0.143	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.0107	0.0676	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.00788	0.0499	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—TNF—ankylosing spondylitis	0.00426	0.0269	CbGpPWpGaD
Dantrolene—Gastrointestinal haemorrhage—Prednisone—ankylosing spondylitis	0.0016	0.00464	CcSEcCtD
Dantrolene—Thrombophlebitis—Methotrexate—ankylosing spondylitis	0.00155	0.00448	CcSEcCtD
Dantrolene—Haemoglobin—Prednisolone—ankylosing spondylitis	0.00154	0.00444	CcSEcCtD
Dantrolene—Haemorrhage—Prednisolone—ankylosing spondylitis	0.00153	0.00442	CcSEcCtD
Dantrolene—Sweating—Methylprednisolone—ankylosing spondylitis	0.0015	0.00433	CcSEcCtD
Dantrolene—Hepatic failure—Methotrexate—ankylosing spondylitis	0.00149	0.00432	CcSEcCtD
Dantrolene—Visual impairment—Prednisolone—ankylosing spondylitis	0.00147	0.00426	CcSEcCtD
Dantrolene—Muscular weakness—Prednisone—ankylosing spondylitis	0.00142	0.00409	CcSEcCtD
Dantrolene—Visual disturbance—Methotrexate—ankylosing spondylitis	0.00142	0.00409	CcSEcCtD
Dantrolene—Haemoglobin—Triamcinolone—ankylosing spondylitis	0.00141	0.00408	CcSEcCtD
Dantrolene—Haemoglobin—Methylprednisolone—ankylosing spondylitis	0.00141	0.00407	CcSEcCtD
Dantrolene—Haemorrhage—Triamcinolone—ankylosing spondylitis	0.00141	0.00406	CcSEcCtD
Dantrolene—Haemorrhage—Methylprednisolone—ankylosing spondylitis	0.0014	0.00405	CcSEcCtD
Dantrolene—Visual impairment—Methylprednisolone—ankylosing spondylitis	0.00135	0.00391	CcSEcCtD
Dantrolene—Erythema—Prednisolone—ankylosing spondylitis	0.00133	0.00385	CcSEcCtD
Dantrolene—Haemoglobin—Dexamethasone—ankylosing spondylitis	0.00128	0.00371	CcSEcCtD
Dantrolene—Haemoglobin—Betamethasone—ankylosing spondylitis	0.00128	0.00371	CcSEcCtD
Dantrolene—Haemorrhage—Dexamethasone—ankylosing spondylitis	0.00127	0.00369	CcSEcCtD
Dantrolene—Haemorrhage—Betamethasone—ankylosing spondylitis	0.00127	0.00369	CcSEcCtD
Dantrolene—Vision blurred—Prednisolone—ankylosing spondylitis	0.00125	0.00362	CcSEcCtD
Dantrolene—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.00123	0.00357	CcSEcCtD
Dantrolene—Depression—Prednisone—ankylosing spondylitis	0.00123	0.00357	CcSEcCtD
Dantrolene—Visual impairment—Dexamethasone—ankylosing spondylitis	0.00123	0.00355	CcSEcCtD
Dantrolene—Visual impairment—Betamethasone—ankylosing spondylitis	0.00123	0.00355	CcSEcCtD
Dantrolene—Erythema—Triamcinolone—ankylosing spondylitis	0.00122	0.00354	CcSEcCtD
Dantrolene—Erythema—Methylprednisolone—ankylosing spondylitis	0.00122	0.00353	CcSEcCtD
Dantrolene—Malaise—Prednisolone—ankylosing spondylitis	0.0012	0.00347	CcSEcCtD
Dantrolene—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.0012	0.00346	CcSEcCtD
Dantrolene—Back pain—Triamcinolone—ankylosing spondylitis	0.00118	0.00342	CcSEcCtD
Dantrolene—Convulsion—Prednisolone—ankylosing spondylitis	0.00115	0.00333	CcSEcCtD
Dantrolene—Hypertension—Prednisolone—ankylosing spondylitis	0.00115	0.00332	CcSEcCtD
Dantrolene—Eosinophilia—Methotrexate—ankylosing spondylitis	0.00115	0.00332	CcSEcCtD
Dantrolene—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.00113	0.00328	CcSEcCtD
Dantrolene—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.00113	0.00327	CcSEcCtD
Dantrolene—Discomfort—Prednisolone—ankylosing spondylitis	0.00112	0.00324	CcSEcCtD
Dantrolene—Haemoglobin—Prednisone—ankylosing spondylitis	0.00112	0.00323	CcSEcCtD
Dantrolene—Haemorrhage—Prednisone—ankylosing spondylitis	0.00111	0.00321	CcSEcCtD
Dantrolene—Erythema—Dexamethasone—ankylosing spondylitis	0.00111	0.00321	CcSEcCtD
Dantrolene—Erythema—Betamethasone—ankylosing spondylitis	0.00111	0.00321	CcSEcCtD
Dantrolene—Malaise—Triamcinolone—ankylosing spondylitis	0.0011	0.00319	CcSEcCtD
Dantrolene—Malaise—Methylprednisolone—ankylosing spondylitis	0.0011	0.00318	CcSEcCtD
Dantrolene—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.00109	0.00314	CcSEcCtD
Dantrolene—Convulsion—Triamcinolone—ankylosing spondylitis	0.00106	0.00306	CcSEcCtD
Dantrolene—Tachycardia—Prednisolone—ankylosing spondylitis	0.00106	0.00306	CcSEcCtD
Dantrolene—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00106	0.00306	CcSEcCtD
Dantrolene—Hypertension—Triamcinolone—ankylosing spondylitis	0.00106	0.00305	CcSEcCtD
Dantrolene—Hypertension—Methylprednisolone—ankylosing spondylitis	0.00105	0.00305	CcSEcCtD
Dantrolene—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00105	0.00303	CcSEcCtD
Dantrolene—Myalgia—Triamcinolone—ankylosing spondylitis	0.00104	0.00301	CcSEcCtD
Dantrolene—Myalgia—Methylprednisolone—ankylosing spondylitis	0.00104	0.003	CcSEcCtD
Dantrolene—Drowsiness—Methotrexate—ankylosing spondylitis	0.00103	0.00299	CcSEcCtD
Dantrolene—Depression—Methotrexate—ankylosing spondylitis	0.00103	0.00298	CcSEcCtD
Dantrolene—Flushing—Prednisone—ankylosing spondylitis	0.00103	0.00298	CcSEcCtD
Dantrolene—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.00103	0.00298	CcSEcCtD
Dantrolene—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.00103	0.00298	CcSEcCtD
Dantrolene—Discomfort—Triamcinolone—ankylosing spondylitis	0.00103	0.00298	CcSEcCtD
Dantrolene—Discomfort—Methylprednisolone—ankylosing spondylitis	0.00103	0.00297	CcSEcCtD
Dantrolene—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00102	0.00295	CcSEcCtD
Dantrolene—Renal failure—Methotrexate—ankylosing spondylitis	0.00102	0.00294	CcSEcCtD
Dantrolene—Confusional state—Methylprednisolone—ankylosing spondylitis	0.001	0.0029	CcSEcCtD
Dantrolene—Malaise—Dexamethasone—ankylosing spondylitis	0.001	0.00289	CcSEcCtD
Dantrolene—Malaise—Betamethasone—ankylosing spondylitis	0.001	0.00289	CcSEcCtD
Dantrolene—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000998	0.00289	CcSEcCtD
Dantrolene—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000996	0.00288	CcSEcCtD
Dantrolene—Sweating—Methotrexate—ankylosing spondylitis	0.000991	0.00287	CcSEcCtD
Dantrolene—Haematuria—Methotrexate—ankylosing spondylitis	0.000986	0.00285	CcSEcCtD
Dantrolene—Insomnia—Prednisolone—ankylosing spondylitis	0.000982	0.00284	CcSEcCtD
Dantrolene—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000974	0.00282	CcSEcCtD
Dantrolene—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000972	0.00281	CcSEcCtD
Dantrolene—Erythema—Prednisone—ankylosing spondylitis	0.000967	0.00279	CcSEcCtD
Dantrolene—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000965	0.00279	CcSEcCtD
Dantrolene—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000963	0.00278	CcSEcCtD
Dantrolene—Convulsion—Betamethasone—ankylosing spondylitis	0.000962	0.00278	CcSEcCtD
Dantrolene—Convulsion—Dexamethasone—ankylosing spondylitis	0.000962	0.00278	CcSEcCtD
Dantrolene—Hypertension—Dexamethasone—ankylosing spondylitis	0.000958	0.00277	CcSEcCtD
Dantrolene—Hypertension—Betamethasone—ankylosing spondylitis	0.000958	0.00277	CcSEcCtD
Dantrolene—Myalgia—Dexamethasone—ankylosing spondylitis	0.000945	0.00273	CcSEcCtD
Dantrolene—Myalgia—Betamethasone—ankylosing spondylitis	0.000945	0.00273	CcSEcCtD
Dantrolene—Discomfort—Dexamethasone—ankylosing spondylitis	0.000934	0.0027	CcSEcCtD
Dantrolene—Discomfort—Betamethasone—ankylosing spondylitis	0.000934	0.0027	CcSEcCtD
Dantrolene—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000933	0.0027	CcSEcCtD
Dantrolene—Pain—Prednisolone—ankylosing spondylitis	0.000928	0.00268	CcSEcCtD
Dantrolene—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000928	0.00268	CcSEcCtD
Dantrolene—Hepatitis—Methotrexate—ankylosing spondylitis	0.000928	0.00268	CcSEcCtD
Dantrolene—Vision blurred—Prednisone—ankylosing spondylitis	0.000911	0.00263	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00091	0.00263	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000907	0.00262	CcSEcCtD
Dantrolene—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000906	0.00262	CcSEcCtD
Dantrolene—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000906	0.00262	CcSEcCtD
Dantrolene—Insomnia—Triamcinolone—ankylosing spondylitis	0.000903	0.00261	CcSEcCtD
Dantrolene—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000901	0.00261	CcSEcCtD
Dantrolene—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000897	0.00259	CcSEcCtD
Dantrolene—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000895	0.00259	CcSEcCtD
Dantrolene—Visual impairment—Methotrexate—ankylosing spondylitis	0.000894	0.00259	CcSEcCtD
Dantrolene—Anaemia—Prednisone—ankylosing spondylitis	0.000893	0.00258	CcSEcCtD
Dantrolene—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000887	0.00256	CcSEcCtD
Dantrolene—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000887	0.00256	CcSEcCtD
Dantrolene—Tachycardia—Betamethasone—ankylosing spondylitis	0.000884	0.00256	CcSEcCtD
Dantrolene—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000884	0.00256	CcSEcCtD
Dantrolene—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000879	0.00254	CcSEcCtD
Dantrolene—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000877	0.00254	CcSEcCtD
Dantrolene—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000876	0.00253	CcSEcCtD
Dantrolene—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000876	0.00253	CcSEcCtD
Dantrolene—Malaise—Prednisone—ankylosing spondylitis	0.000872	0.00252	CcSEcCtD
Dantrolene—Anorexia—Dexamethasone—ankylosing spondylitis	0.000863	0.0025	CcSEcCtD
Dantrolene—Anorexia—Betamethasone—ankylosing spondylitis	0.000863	0.0025	CcSEcCtD
Dantrolene—Urticaria—Prednisolone—ankylosing spondylitis	0.000862	0.00249	CcSEcCtD
Dantrolene—Fatigue—Triamcinolone—ankylosing spondylitis	0.000861	0.00249	CcSEcCtD
Dantrolene—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000859	0.00248	CcSEcCtD
Dantrolene—Pain—Triamcinolone—ankylosing spondylitis	0.000854	0.00247	CcSEcCtD
Dantrolene—Convulsion—Prednisone—ankylosing spondylitis	0.000837	0.00242	CcSEcCtD
Dantrolene—Hypertension—Prednisone—ankylosing spondylitis	0.000834	0.00241	CcSEcCtD
Dantrolene—Chills—Methotrexate—ankylosing spondylitis	0.000833	0.00241	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000825	0.00239	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000825	0.00239	CcSEcCtD
Dantrolene—Myalgia—Prednisone—ankylosing spondylitis	0.000823	0.00238	CcSEcCtD
Dantrolene—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000823	0.00238	CcSEcCtD
Dantrolene—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000821	0.00237	CcSEcCtD
Dantrolene—Insomnia—Betamethasone—ankylosing spondylitis	0.000819	0.00237	CcSEcCtD
Dantrolene—Insomnia—Dexamethasone—ankylosing spondylitis	0.000819	0.00237	CcSEcCtD
Dantrolene—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000814	0.00236	CcSEcCtD
Dantrolene—Discomfort—Prednisone—ankylosing spondylitis	0.000813	0.00235	CcSEcCtD
Dantrolene—Erythema—Methotrexate—ankylosing spondylitis	0.000808	0.00234	CcSEcCtD
Dantrolene—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.0008	0.00231	CcSEcCtD
Dantrolene—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000797	0.00231	CcSEcCtD
Dantrolene—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000797	0.00231	CcSEcCtD
Dantrolene—Urticaria—Triamcinolone—ankylosing spondylitis	0.000793	0.00229	CcSEcCtD
Dantrolene—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000791	0.00229	CcSEcCtD
Dantrolene—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000791	0.00229	CcSEcCtD
Dantrolene—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000789	0.00228	CcSEcCtD
Dantrolene—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000789	0.00228	CcSEcCtD
Dantrolene—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000787	0.00228	CcSEcCtD
Dantrolene—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000787	0.00228	CcSEcCtD
Dantrolene—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000787	0.00228	CcSEcCtD
Dantrolene—Back pain—Methotrexate—ankylosing spondylitis	0.000781	0.00226	CcSEcCtD
Dantrolene—Fatigue—Betamethasone—ankylosing spondylitis	0.000781	0.00226	CcSEcCtD
Dantrolene—Fatigue—Dexamethasone—ankylosing spondylitis	0.000781	0.00226	CcSEcCtD
Dantrolene—Pain—Dexamethasone—ankylosing spondylitis	0.000775	0.00224	CcSEcCtD
Dantrolene—Pain—Betamethasone—ankylosing spondylitis	0.000775	0.00224	CcSEcCtD
Dantrolene—Tachycardia—Prednisone—ankylosing spondylitis	0.00077	0.00223	CcSEcCtD
Dantrolene—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000763	0.00221	CcSEcCtD
Dantrolene—Vision blurred—Methotrexate—ankylosing spondylitis	0.000761	0.0022	CcSEcCtD
Dantrolene—Anorexia—Prednisone—ankylosing spondylitis	0.000752	0.00217	CcSEcCtD
Dantrolene—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000749	0.00217	CcSEcCtD
Dantrolene—Anaemia—Methotrexate—ankylosing spondylitis	0.000747	0.00216	CcSEcCtD
Dantrolene—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000746	0.00216	CcSEcCtD
Dantrolene—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000746	0.00216	CcSEcCtD
Dantrolene—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000741	0.00214	CcSEcCtD
Dantrolene—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000741	0.00214	CcSEcCtD
Dantrolene—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000735	0.00213	CcSEcCtD
Dantrolene—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000734	0.00212	CcSEcCtD
Dantrolene—Malaise—Methotrexate—ankylosing spondylitis	0.000728	0.00211	CcSEcCtD
Dantrolene—Leukopenia—Methotrexate—ankylosing spondylitis	0.000723	0.00209	CcSEcCtD
Dantrolene—Urticaria—Dexamethasone—ankylosing spondylitis	0.00072	0.00208	CcSEcCtD
Dantrolene—Urticaria—Betamethasone—ankylosing spondylitis	0.00072	0.00208	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000719	0.00208	CcSEcCtD
Dantrolene—Dizziness—Prednisolone—ankylosing spondylitis	0.000718	0.00208	CcSEcCtD
Dantrolene—Asthenia—Triamcinolone—ankylosing spondylitis	0.000716	0.00207	CcSEcCtD
Dantrolene—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000716	0.00207	CcSEcCtD
Dantrolene—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000716	0.00207	CcSEcCtD
Dantrolene—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000716	0.00207	CcSEcCtD
Dantrolene—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000716	0.00207	CcSEcCtD
Dantrolene—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000715	0.00207	CcSEcCtD
Dantrolene—Insomnia—Prednisone—ankylosing spondylitis	0.000713	0.00206	CcSEcCtD
Dantrolene—Pruritus—Triamcinolone—ankylosing spondylitis	0.000706	0.00204	CcSEcCtD
Dantrolene—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000705	0.00204	CcSEcCtD
Dantrolene—Convulsion—Methotrexate—ankylosing spondylitis	0.0007	0.00202	CcSEcCtD
Dantrolene—Dyspepsia—Prednisone—ankylosing spondylitis	0.000694	0.00201	CcSEcCtD
Dantrolene—Myalgia—Methotrexate—ankylosing spondylitis	0.000688	0.00199	CcSEcCtD
Dantrolene—Decreased appetite—Prednisone—ankylosing spondylitis	0.000686	0.00198	CcSEcCtD
Dantrolene—Rash—Prednisolone—ankylosing spondylitis	0.000684	0.00198	CcSEcCtD
Dantrolene—Dermatitis—Prednisolone—ankylosing spondylitis	0.000684	0.00198	CcSEcCtD
Dantrolene—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000682	0.00197	CcSEcCtD
Dantrolene—Fatigue—Prednisone—ankylosing spondylitis	0.00068	0.00197	CcSEcCtD
Dantrolene—Headache—Prednisolone—ankylosing spondylitis	0.00068	0.00197	CcSEcCtD
Dantrolene—Discomfort—Methotrexate—ankylosing spondylitis	0.000679	0.00196	CcSEcCtD
Dantrolene—Constipation—Prednisone—ankylosing spondylitis	0.000675	0.00195	CcSEcCtD
Dantrolene—Confusional state—Methotrexate—ankylosing spondylitis	0.000665	0.00192	CcSEcCtD
Dantrolene—Dizziness—Triamcinolone—ankylosing spondylitis	0.00066	0.00191	CcSEcCtD
Dantrolene—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000659	0.00191	CcSEcCtD
Dantrolene—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000659	0.0019	CcSEcCtD
Dantrolene—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00065	0.00188	CcSEcCtD
Dantrolene—Asthenia—Betamethasone—ankylosing spondylitis	0.00065	0.00188	CcSEcCtD
Dantrolene—Asthenia—Dexamethasone—ankylosing spondylitis	0.00065	0.00188	CcSEcCtD
Dantrolene—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000645	0.00187	CcSEcCtD
Dantrolene—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000645	0.00187	CcSEcCtD
Dantrolene—Nausea—Prednisolone—ankylosing spondylitis	0.000645	0.00186	CcSEcCtD
Dantrolene—Pruritus—Betamethasone—ankylosing spondylitis	0.000641	0.00185	CcSEcCtD
Dantrolene—Pruritus—Dexamethasone—ankylosing spondylitis	0.000641	0.00185	CcSEcCtD
Dantrolene—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000637	0.00184	CcSEcCtD
Dantrolene—Vomiting—Triamcinolone—ankylosing spondylitis	0.000635	0.00184	CcSEcCtD
Dantrolene—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000633	0.00183	CcSEcCtD
Dantrolene—Rash—Triamcinolone—ankylosing spondylitis	0.000629	0.00182	CcSEcCtD
Dantrolene—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000629	0.00182	CcSEcCtD
Dantrolene—Anorexia—Methotrexate—ankylosing spondylitis	0.000628	0.00182	CcSEcCtD
Dantrolene—Rash—Methylprednisolone—ankylosing spondylitis	0.000628	0.00182	CcSEcCtD
Dantrolene—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000627	0.00181	CcSEcCtD
Dantrolene—Urticaria—Prednisone—ankylosing spondylitis	0.000627	0.00181	CcSEcCtD
Dantrolene—Headache—Triamcinolone—ankylosing spondylitis	0.000625	0.00181	CcSEcCtD
Dantrolene—Headache—Methylprednisolone—ankylosing spondylitis	0.000624	0.0018	CcSEcCtD
Dantrolene—Abdominal pain—Prednisone—ankylosing spondylitis	0.000624	0.0018	CcSEcCtD
Dantrolene—Body temperature increased—Prednisone—ankylosing spondylitis	0.000624	0.0018	CcSEcCtD
Dantrolene—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00062	0.00179	CcSEcCtD
Dantrolene—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00062	0.00179	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000601	0.00174	CcSEcCtD
Dantrolene—Dizziness—Dexamethasone—ankylosing spondylitis	0.000599	0.00173	CcSEcCtD
Dantrolene—Dizziness—Betamethasone—ankylosing spondylitis	0.000599	0.00173	CcSEcCtD
Dantrolene—Insomnia—Methotrexate—ankylosing spondylitis	0.000596	0.00172	CcSEcCtD
Dantrolene—Nausea—Triamcinolone—ankylosing spondylitis	0.000593	0.00171	CcSEcCtD
Dantrolene—Nausea—Methylprednisolone—ankylosing spondylitis	0.000592	0.00171	CcSEcCtD
Dantrolene—Somnolence—Methotrexate—ankylosing spondylitis	0.000586	0.00169	CcSEcCtD
Dantrolene—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000581	0.00168	CcSEcCtD
Dantrolene—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00058	0.00168	CcSEcCtD
Dantrolene—Vomiting—Dexamethasone—ankylosing spondylitis	0.000576	0.00167	CcSEcCtD
Dantrolene—Vomiting—Betamethasone—ankylosing spondylitis	0.000576	0.00167	CcSEcCtD
Dantrolene—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000573	0.00166	CcSEcCtD
Dantrolene—Rash—Dexamethasone—ankylosing spondylitis	0.000571	0.00165	CcSEcCtD
Dantrolene—Rash—Betamethasone—ankylosing spondylitis	0.000571	0.00165	CcSEcCtD
Dantrolene—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000571	0.00165	CcSEcCtD
Dantrolene—Dermatitis—Betamethasone—ankylosing spondylitis	0.000571	0.00165	CcSEcCtD
Dantrolene—Fatigue—Methotrexate—ankylosing spondylitis	0.000568	0.00164	CcSEcCtD
Dantrolene—Headache—Dexamethasone—ankylosing spondylitis	0.000567	0.00164	CcSEcCtD
Dantrolene—Headache—Betamethasone—ankylosing spondylitis	0.000567	0.00164	CcSEcCtD
Dantrolene—Asthenia—Prednisone—ankylosing spondylitis	0.000566	0.00164	CcSEcCtD
Dantrolene—Pain—Methotrexate—ankylosing spondylitis	0.000564	0.00163	CcSEcCtD
Dantrolene—Pruritus—Prednisone—ankylosing spondylitis	0.000558	0.00161	CcSEcCtD
Dantrolene—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000543	0.00157	CcSEcCtD
Dantrolene—Diarrhoea—Prednisone—ankylosing spondylitis	0.00054	0.00156	CcSEcCtD
Dantrolene—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000539	0.00156	CcSEcCtD
Dantrolene—Nausea—Dexamethasone—ankylosing spondylitis	0.000538	0.00156	CcSEcCtD
Dantrolene—Nausea—Betamethasone—ankylosing spondylitis	0.000538	0.00156	CcSEcCtD
Dantrolene—Urticaria—Methotrexate—ankylosing spondylitis	0.000524	0.00151	CcSEcCtD
Dantrolene—Dizziness—Prednisone—ankylosing spondylitis	0.000522	0.00151	CcSEcCtD
Dantrolene—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000521	0.00151	CcSEcCtD
Dantrolene—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000521	0.00151	CcSEcCtD
Dantrolene—Vomiting—Prednisone—ankylosing spondylitis	0.000502	0.00145	CcSEcCtD
Dantrolene—Rash—Prednisone—ankylosing spondylitis	0.000497	0.00144	CcSEcCtD
Dantrolene—Dermatitis—Prednisone—ankylosing spondylitis	0.000497	0.00144	CcSEcCtD
Dantrolene—Headache—Prednisone—ankylosing spondylitis	0.000494	0.00143	CcSEcCtD
Dantrolene—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000486	0.0014	CcSEcCtD
Dantrolene—Asthenia—Methotrexate—ankylosing spondylitis	0.000473	0.00137	CcSEcCtD
Dantrolene—Nausea—Prednisone—ankylosing spondylitis	0.000469	0.00135	CcSEcCtD
Dantrolene—Pruritus—Methotrexate—ankylosing spondylitis	0.000466	0.00135	CcSEcCtD
Dantrolene—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000451	0.0013	CcSEcCtD
Dantrolene—Dizziness—Methotrexate—ankylosing spondylitis	0.000436	0.00126	CcSEcCtD
Dantrolene—Vomiting—Methotrexate—ankylosing spondylitis	0.000419	0.00121	CcSEcCtD
Dantrolene—Rash—Methotrexate—ankylosing spondylitis	0.000416	0.0012	CcSEcCtD
Dantrolene—Dermatitis—Methotrexate—ankylosing spondylitis	0.000415	0.0012	CcSEcCtD
Dantrolene—Headache—Methotrexate—ankylosing spondylitis	0.000413	0.00119	CcSEcCtD
Dantrolene—Nausea—Methotrexate—ankylosing spondylitis	0.000392	0.00113	CcSEcCtD
Dantrolene—CYP3A4—Metabolism—B3GNT2—ankylosing spondylitis	0.000114	0.000723	CbGpPWpGaD
